Industry Focus: 2025 GMP Full Implementation Drives Solid Dosage Equipment Upgrade Wave, Lysino Machinery’s Core Products Empower Pharmaceutical Compliance Transformation
Release Date: May 15, 2026 | Source: Pharmaceutical Equipment Industry Observer
On July 1, 2026, the Good Manufacturing Practice for Pharmaceuticals (2025 Revision) will be fully implemented nationwide. As the most significant policy adjustment in China’s pharmaceutical industry over the past decade, the new GMP for the first time incorporates "data-driven decision-making", "full-process traceability" and "intelligent manufacturing" as mandatory clauses, imposing unprecedentedly stringent requirements on process control, quality assurance and data integrity in solid dosage production.
Driven by this policy, pharmaceutical enterprises across China are launching a new round of solid dosage production line upgrading and transformation. Industry data shows that in the first quarter of 2026, domestic solid dosage equipment procurement orders increased by 37.2% year-on-year, with intelligent equipment compliant with the 2025 GMP accounting for over 75% of total orders. As a leading domestic provider of solid dosage equipment solutions, Liaoyang Lysino Machinery Co., Ltd. has become the preferred partner for numerous pharmaceutical enterprises in compliance upgrading, leveraging its profound technical accumulation in dry granulation, capsule filling, counting and packaging.
Three Core Requirements of the New GMP Force Comprehensive Upgrade of Solid Dosage Equipment
The 2025 GMP puts forward three core upgrade requirements for solid dosage production equipment, directly driving industry technological iteration:
-
Data Integrity Requirements: All critical process parameters must be collected in real time, automatically recorded and tamper-proof, and must comply with FDA 21 CFR Part 11 electronic record standards. This requires equipment to have a complete PLC+SCADA+MES three-level control architecture, realizing full-process data traceability from raw material incoming to finished product delivery.
-
Process Control Precision Requirements: The control standards for critical quality attributes such as mixing uniformity, granule quality, fill weight variation and tablet weight variation have been significantly raised. For example, the allowable range of capsule fill weight variation has been tightened from ±7.5% to ±5%, and tablet hardness fluctuation range from ±10% to ±5%.
-
Continuous and Intelligent Production Requirements: Enterprises are encouraged to adopt continuous production technology and intelligent manufacturing systems to reduce manual intervention and improve production efficiency and batch consistency. Online quality inspection, predictive maintenance and digital twin technologies have become standard configurations for new production lines.
Lysino Machinery’s Core Products Fully Compliant with 2025 GMP Requirements
In response to the stringent requirements of the new GMP, Lysino Machinery has comprehensively upgraded its full product line. All equipment has passed 2025 GMP compliance verification, providing pharmaceutical enterprises with one-stop compliance solutions from granulation, filling to packaging.
1. GLZ Series Dry Granulator: Intelligent Closed-loop Control Ensures Granule Quality Consistency
Dry granulation is the core link in solid dosage production, and granule quality directly affects the stability of subsequent tableting and filling processes. Lysino Machinery’s independently developed GLZ-120 Dry Granulator adopts an intelligent pressure feedback system that automatically adjusts roller pressure and speed according to material characteristics, avoiding problems such as tablet cracking and excessive fine powder.
- Equipped with online granule particle size and moisture detection system to realize closed-loop control, with granule qualification rate increased to over 99.5%
- Fully enclosed dust-free design completely solves dust leakage and cross-contamination problems
- Integrated MES system interface for real-time upload of all process parameters to meet data traceability requirements
- Modular design enables mold replacement within 15 minutes, adapting to multi-variety and small-batch production
2. NJP Series Automatic Capsule Filling Machine: High-precision Servo Control with Fill Weight Variation ≤±3%
Capsule filling is the most precision-demanding process, and the new GMP has particularly strict requirements for fill weight variation. Lysino Machinery’s NJP-1200C Automatic Capsule Filling Machine adopts servo motor drive and electromagnetic vibration feeding technology, combined with real-time feedback from high-precision weighing sensors, controlling fill weight variation within ±3%, far exceeding national standards.
- Maximum capacity of 1,200 capsules per minute with stable operation and low failure rate
- Integrated AI visual inspection system automatically rejects unqualified products such as empty capsules, missing pills and poor locking
- Compliant with cGMP and FDA requirements, supporting export to European and American markets
- Quick mold change design enables switching between different capsule specifications within 30 minutes
3. SNZ Series Intelligent Counting & Cartoning Production Line: Full-process Automation with Zero Manual Intervention
Counting and packaging are the final links in solid dosage production and also critical checkpoints for quality control. The fully automatic production line composed of Lysino Machinery’s SNZ-120 Horizontal Cartoning Machine and intelligent counting machine realizes full-process automation from counting, bottling, capping, labeling to cartoning and sealing with zero manual intervention.
- The intelligent counting machine adopts 3D visual recognition technology with 99.99% counting accuracy and unqualified rate lower than 1/100,000
- Integrated online weight detection, metal detection and visual inspection systems to ensure product quality
- All process data is automatically recorded, realizing full traceability of each bottle of product
- Flexible design enables quick switching between different specifications of tablets, capsules and pills
Lysino Machinery’s One-stop Service Helps Pharmaceutical Enterprises Complete Compliance Upgrade Rapidly
In addition to providing high-quality equipment, Lysino Machinery also provides pharmaceutical enterprises with one-stop services from process design, equipment selection, installation and commissioning to personnel training, validation documents and after-sales maintenance, helping enterprises complete production line upgrading and transformation quickly and cost-effectively.
- Process Validation Services: Provide complete DQ/IQ/OQ/PQ validation documents to ensure smooth passage of GMP inspections
- Customized Solutions: Tailor production line solutions according to enterprises’ product characteristics and capacity requirements
- Fast-response After-sales Service: Established a nationwide after-sales service network to respond to customer needs within 24 hours
- Lifelong Technical Support: Provide equipment upgrading and technical consulting services to ensure long-term stable operation of equipment
Currently, Lysino Machinery’s equipment has served more than 300 pharmaceutical enterprises nationwide, helping numerous customers successfully pass the new GMP certification. With the full implementation of the 2025 GMP, Lysino Machinery will continue to increase investment in technological research and development, continuously launch more advanced and intelligent solid dosage equipment, and contribute to the high-quality development of China’s pharmaceutical industry.